LOJACONO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 6.950
EU - Europa 4.029
AS - Asia 3.191
SA - Sud America 609
AF - Africa 64
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.864
Nazione #
US - Stati Uniti d'America 6.859
CN - Cina 1.193
SG - Singapore 1.069
UA - Ucraina 809
DE - Germania 754
PL - Polonia 678
IT - Italia 521
BR - Brasile 515
HK - Hong Kong 387
GB - Regno Unito 252
FI - Finlandia 224
RU - Federazione Russa 219
FR - Francia 214
VN - Vietnam 141
TR - Turchia 131
IE - Irlanda 129
EE - Estonia 92
IN - India 81
MX - Messico 46
BD - Bangladesh 42
SE - Svezia 36
ZA - Sudafrica 33
CA - Canada 31
AR - Argentina 29
BE - Belgio 21
IQ - Iraq 21
EC - Ecuador 19
JP - Giappone 17
ID - Indonesia 16
SA - Arabia Saudita 15
UZ - Uzbekistan 14
AT - Austria 12
AU - Australia 12
ES - Italia 12
NL - Olanda 12
CO - Colombia 10
PK - Pakistan 10
EG - Egitto 9
CL - Cile 8
EU - Europa 8
UY - Uruguay 8
CZ - Repubblica Ceca 6
IR - Iran 6
KZ - Kazakistan 6
TH - Thailandia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
MU - Mauritius 5
PY - Paraguay 5
BG - Bulgaria 4
DZ - Algeria 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
HR - Croazia 3
MA - Marocco 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DK - Danimarca 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
NI - Nicaragua 1
PH - Filippine 1
PW - Palau 1
Totale 14.861
Città #
Fairfield 815
Woodbridge 710
Warsaw 677
Jacksonville 576
Singapore 520
Ashburn 505
Houston 440
Hong Kong 383
Ann Arbor 344
Chandler 323
Cambridge 319
Seattle 300
Wilmington 284
Beijing 273
Princeton 244
Nanjing 220
Los Angeles 186
New York 176
Buffalo 131
Dublin 129
Istanbul 109
Helsinki 107
Tallinn 92
Nanchang 83
Des Moines 67
Dearborn 66
Milan 60
Moscow 60
The Dalles 59
Shenyang 56
Lancaster 53
Munich 53
São Paulo 52
Ho Chi Minh City 50
Hebei 47
San Diego 46
Changsha 45
Shanghai 41
Verona 36
Jinan 35
Tianjin 35
Rome 33
San Francisco 32
Brescia 31
Jiaxing 29
Nürnberg 26
Dallas 25
Santa Clara 24
Chicago 23
Hangzhou 23
Redondo Beach 23
London 22
Zhengzhou 22
Guangzhou 21
Hanoi 21
Brussels 20
Genova 20
Dong Ket 18
Johannesburg 17
Phoenix 17
Taizhou 17
Tokyo 17
Chennai 16
Denver 16
Belo Horizonte 14
Boardman 14
Ningbo 14
Rio de Janeiro 14
Tashkent 13
Turku 13
Monterrey 12
Poplar 12
Brasília 11
Guayaquil 11
Kunming 11
Mexico City 11
Toronto 11
Brooklyn 10
Falkenstein 10
Lanzhou 10
Nuremberg 10
Auburn Hills 9
Charlotte 9
Dhaka 9
Porto Alegre 9
Ribeirão Preto 9
Taiyuan 9
Baghdad 8
Cape Town 8
Changchun 8
Curitiba 8
Florence 8
Leawood 8
Manchester 8
Montreal 8
Mumbai 8
Riyadh 8
San Mateo 8
Bari 7
Biên Hòa 7
Totale 9.677
Nome #
Bambini pretermine: nati per vivere 345
Parto e puerperio: i vissuti delle donne in un'ottica di ricerca multidisciplinare. 305
Variabili psicologiche materne e andamento del parto: rilevazione in un campione di donne italiane alla prima esperienza di parto. 300
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 292
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 272
Percorso nascita: un progetto di ricerca multidisciplinare. 256
Long-term outcome of children of rheumatic disease patients 214
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 184
L’approccio multidisciplinare alla nascita: parto, puerperio, visti dalle donne. 177
Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise 173
Children born to SLE and APS mothers 171
Dinoprostone per l'induzione del travaglio di parto in pazienti con Bishop score favorevole: confronto tra gel vaginale e pessario vaginale a rilascio prolungato 169
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 167
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 167
Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study 158
L’approccio multidisciplinare alla nascita: parto e puerperio visti dalle donne. 153
Labor course and delivery in epidural analgesia: a case-control study 151
A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score 151
Uterine artery velocimetry in patients with gestational hypertension 150
Prophylactic oral nifedipine to reduce preterm delivery: a randomized controlled trial in women at high risk 150
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 147
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies 145
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 145
Pregnancy complications of the antiphospholipid syndrome 143
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 143
Neuropsychological development of children born to patients with systemic lupus erythematosus 141
Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. 141
Impact of in utero environment on the offspring of lupus patients 141
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 139
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 138
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 136
Predictors of maternal and fetal complications in SLE patients: a prospective study 133
Offspring of Women with Systemic Autoimmune diseases: fetal and neonatal complications and inheritance of autoimmune diseases. 133
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 132
Neonatal outcome in patients with rheumatic disease 132
Autoimmunity and pregnancy: autoantibodies and pregnancy in rheumatic diseases 132
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 132
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 131
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 129
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 129
Neonatal effects of maternal antiphospholipid syndrome. 129
Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease 128
The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases 127
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 126
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents 125
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 125
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 125
Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study 124
Pregnancy and neonatal outcome in primary antiphospholipid syndrome. 123
European registry of babies born to mothers with antiphospholipid syndrome. 121
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. 119
Autoantibodies and prediction of reproductive failure. 118
Neonates born from mothers with autoimmune disorders 117
The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. 117
Complement Activation and Pregnancy Failure. 116
Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome 116
Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and in preeclampsia 115
Neuropsychological development of children born to patients with antiphospholipid syndrome. 114
Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction 113
Anti-{beta}2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? 113
Is it possible to differentiate "Natural" Antiphospholipid antibodies from "Thrombophilic" ones? Analysis of the fine specificity against the domains of Beta2glycoprotein I 111
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 111
Transabdominal uterine arteries Doppler between 11-14 weeks of gestation for prediction of outcome in high risk pregnancies 109
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 107
Infertility in women with systemic autoimmune diseases 106
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 105
IgG anti-B2glycoprotein I antibodies form one-year-old children born to mothers with systemic autoimmune diseases preferentially target domain 4/5 103
External cephalic version for breech presentation at term: an effective procedure to reduce the caesarean section rate 102
Outcome of infants from mothers with anti-SSA/Ro antibodies. 102
Variabili psicologiche materne e andamento clinico del parto 102
THE FINE SPECIFICITY OF ANTI-BETA2GLYCOPROTEIN I ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES IS PREFERENTIALLY DIRECTED AGAINST DOMAIN 1 100
ANTICORPI ANTIFOSFOLIPIDI: E' POSSIBILE DISTINGUERE GLI ANTICORPI "INNOCENTI" DA QUELLI "TROMBOFILICI"? ANALISI DELLA FINE SPECIFICITA' DIRETTA VERSO I DOMINI DELLA BETA2GLICOPROTEINA I 100
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 100
Pregnancy in systemic sclerosis: a prospective study 99
LA FINE SPECIFICITA' DEGLI ANTICORPI ANTI-BETA2GLICOPROTEINA I NELLE MALATTIE AUTOIMMUNI SISTEMICHE E' PREVALENTEMENTE DIRETTA ERSO IL DOMINIO 1 99
LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME 99
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome 98
Systemic lupus erythematosus and pregnancy: a prospective study. 98
Anti beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome 97
Assistenza e sorveglianza nel travaglio di parto a basso rischio 97
Autoimmune diseases and pregnancy 97
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. 96
Finespecificity of anti-B2glycoprotein I antibodies in sysemic autoimmune diseasesis mostly directed against domain 1 95
Obstetric manifestation of the Antiphospholipid Syndrome 94
Thrombophilia is a risk factor for severe preeclampsia and its recurrence 94
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 93
One-year-old children born to mothers with systemic autoimmune diseases may develop anti-beta2GPI IGg antibodies that preferentially target domain 4/5 93
Contraception in adolescents with systemic lupus erythematosus 92
ONE-YEAR-OLD CHILDREN BORN TO MOTHERS WITH SYSTEMIC AUTOIMMUNE DISEASES MAY DEVELOP ANTI-BETA2GPI IGG ANTIBODIES THAT PREFERENTIALLY TARGET DOMAIN 4/5 92
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases 92
Gestational success in patients at risk of preterm labor with presence of ureaplasma urealyticum in cervico-vaginal secretions 91
Novel aspects of Sjögren’s syndrome in 2012 91
PROPOSTA DI UNA TECNOLOGIA OSTETRICA: IL PIANO DI ASSISTENZA OSTETRICA NELLA SORVEGLIANZA DEL BENESSERE MATERNO/FETALE INTRAPARTUM 90
Esperienza personale nel trattamento delle emorragie gastroduodenali mediante l'associazione di somatostatina e ranitidina 90
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 90
SAT0018 Neurodevelopmental Long Term Outcome in Children Born to Mothers with Systemic Lupus Erythematosus and Antiphospholipid Syndrome 89
Variabili psicologiche materne e andamento clinico del parto 88
Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin 87
Cytokine gene polymorphisms and preeclampsia 87
SICUREZZA DEI FARMACI BIOLOGICI ANTI-TNF IN GRAVIDANZA 86
Totale 13.130
Categoria #
all - tutte 66.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.544


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.160 0 0 0 0 0 229 56 209 246 156 199 65
2021/2022949 39 169 18 49 13 50 38 67 41 119 93 253
2022/20231.017 138 7 26 78 104 261 4 105 173 5 42 74
2023/2024859 75 27 50 71 36 158 33 37 217 15 2 138
2024/20252.102 9 26 14 342 213 198 177 85 199 134 431 274
2025/20262.360 377 596 397 577 357 56 0 0 0 0 0 0
Totale 15.089